Cirrhosis News and Research

Latest Cirrhosis News and Research

Over-the-counter and prescription pain medications linked to drug-induced liver injury

More than 1,000 medications, with acetaminophen being the most common, have been associated with drug-induced liver injury.

30 Nov 2016

Research provides insight into molecular mechanisms involved in immune response to HBV

The innate immune system in mammals defends against infection from viruses and other microbial infections.

28 Nov 2016

Women more susceptible to damaging effects of alcohol, says Houston Methodist expert

"One drink a day might be too much for a woman who has a genetic pre-disposition to cirrhosis of the liver," said Howard Monsour, M.D., chief of hepatology at Houston Methodist Hospital "One drink for a woman has about twice the effect as it does for the same amount consumed by a man."

22 Nov 2016

Low-calorie diet and exercise could improve kidney function in patients with NASH

Non-alcoholic steatohepatitis (NASH) is a potentially serious liver condition characterized by excess fat in the liver associated with inflammation and scarring.

21 Nov 2016

Study finds way to increase liver cancer screening rates among at-risk cirrhosis patients

Proactive outreach to cirrhosis patients in a safety net health system successfully doubled their screening rates for liver cancer, UT Southwestern Medical Center researchers found.

18 Nov 2016

Hepatitis C virus sabotages antiviral defenses of liver cells by blunting effect of immune proteins

The virus that causes hepatitis C protects itself by blocking signals that call up immune defenses in liver cells, according to University of Washington researchers and colleagues reporting Nov. 14 in Nature Medicine.

17 Nov 2016

HCV patients treated with DAA therapy not at increased risk of developing liver cancer, study finds

A new study presented this week at The Liver Meeting — held by the American Association for the Study of Liver Diseases — found patients with hepatitis C who take direct-acting antiviral medication are at no higher risk for developing liver cancer than those who do not take the medication.

11 Nov 2016

High-protein diets may help prevent chronic diseases by reducing liver fat

According to a new nutritional study conducted by the German Institute of Human Nutrition on individuals with type 2 diabetes, high-protein diets reduced liver fat by up to 48 percent within six weeks. It did not matter whether the diet was mainly based on plant or animal protein.

2 Nov 2016

Many Canadian territories restrict access to medications for treating hepatitis C, study finds

A study conducted by Canadian and Australian researchers shows that nearly everywhere in Canada, the provinces and territories impose obstacles to reimbursement of new direct-acting antivirals (DAA) to treat hepatitis C by because of their cost.

14 Oct 2016

Japanese researchers identify mechanism for hormone that limits liver fibrosis

Nonalcoholic steatohepatitis (NASH) has been emerging worldwide and effective treatment, especially for liver fibrosis, is essential for improving the prognosis.

13 Oct 2016

Common drug for allergies and asthma could prevent fibrosis, reduce need for liver transplants

A drug commonly used for the prevention of allergies and asthma someday could find new use in preventing liver disease and reducing the need for transplants, according to new research published in the October 2016 edition of the scientific journal Hepatology.

12 Oct 2016

Novel method can quantify progression of NAFLD to more advanced fibrosis and cirrhosis

Combining multiple non-invasive measures, researchers at University of California San Diego School of Medicine describe a novel method to quantify the progression of nonalcoholic fatty liver disease (NAFLD) to its more dangerous and deadly states — advanced fibrosis and cirrhosis.

12 Oct 2016

New non-invasive method could improve diagnosis of severe liver disease

A new non-invasive method of predicting the risk of developing a severe form of liver disease could ensure patients receive early and potentially life-saving medical intervention before irreversible damage is done.

6 Oct 2016

Bile acid transporter inhibitors can prevent NASH in mice, study shows

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of Atlanta have shown.

21 Sep 2016

UofL investigators to explore liver disease in comprehensive fashion

Liver diseases are clinically important health problems and are generally underappreciated. The University of Louisville has brought together a critical mass of investigators to study liver diseases in a comprehensive fashion.

14 Sep 2016

Experts recommend removal of restrictions in accessing new hepatitis C therapies for drug users

Global health experts are today are calling for the removal of restrictions preventing people who use drugs from accessing new hepatitis C cures. So long as these restrictions exist, the goal of disease elimination will remain out of reach, they say.

7 Sep 2016

New discovery could potentially lead to treatments for Crohn's disease

Scientists at the University of British Columbia have made a discovery that could potentially lead to treatments for a debilitating complication of Crohn's disease.

2 Sep 2016

Low selenium levels linked to liver cancer risk? An interview with Dr David Hughes

Food provides us with a variety of substances we need to maintain life. These substances are essential nutrients and are classified as macronutrients (water, protein, fats, and carbohydrates) and micronutrients (vitamins and minerals).

22 Aug 2016

Hydrothermal DMR results show promise in treatment of type 2 diabetes

Fractyl Laboratories Inc. (Fractyl) announced today publication of data in the current issue of Diabetes Care from the Company’s first-in-human study of RevitaTM duodenal mucosal resurfacing (Revita DMR).

17 Aug 2016

Increased treatment for HCV in Rhode Island could help eradicate disease by 2030

A new Brown University study projects that increasing the number of Rhode Islanders treated every year for hepatitis C virus infection (HCV) to about 2,000 by 2020 would reduce cases by 90 percent and prevent more than 70 percent of expected liver-related deaths in the state by 2030.

5 Aug 2016

Cirrhosis News and Research

Latest Cirrhosis News and Research

Over-the-counter and prescription pain medications linked to drug-induced liver injury

Research provides insight into molecular mechanisms involved in immune response to HBV

Women more susceptible to damaging effects of alcohol, says Houston Methodist expert

Low-calorie diet and exercise could improve kidney function in patients with NASH

Study finds way to increase liver cancer screening rates among at-risk cirrhosis patients

Hepatitis C virus sabotages antiviral defenses of liver cells by blunting effect of immune proteins

HCV patients treated with DAA therapy not at increased risk of developing liver cancer, study finds

High-protein diets may help prevent chronic diseases by reducing liver fat

Many Canadian territories restrict access to medications for treating hepatitis C, study finds

Japanese researchers identify mechanism for hormone that limits liver fibrosis

Common drug for allergies and asthma could prevent fibrosis, reduce need for liver transplants

Novel method can quantify progression of NAFLD to more advanced fibrosis and cirrhosis

New non-invasive method could improve diagnosis of severe liver disease

Bile acid transporter inhibitors can prevent NASH in mice, study shows

UofL investigators to explore liver disease in comprehensive fashion

Experts recommend removal of restrictions in accessing new hepatitis C therapies for drug users

New discovery could potentially lead to treatments for Crohn's disease

Low selenium levels linked to liver cancer risk? An interview with Dr David Hughes

Hydrothermal DMR results show promise in treatment of type 2 diabetes

Increased treatment for HCV in Rhode Island could help eradicate disease by 2030

Pharmaceutical Manufacturing - Industry Focus eBook eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Cirrhosis News and Research

Latest Cirrhosis News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in